Article · 29 May 2023
Conference abstractPublished 23 Nov 2012
Indian pharmaceutical sector- Current scenario
Abstract
Select any words in the title or abstract, or press this and choose a sentence.
In the past few years, Indian Pharmaceutical industry has grown by leaps and bounds. Several factors have acted as a driving force for this ? a) rising household income levels, b) increasing prevalence of lifestyle related diseases, c) improving healthcare infrastructure/delivery systems. Not only MNC?s but also the domestic market has emerged enormously making India a lucrative destination of clinical trials for global giants. Indian pharmaceutical market grew at 15.7% during December 2011. The quality of the filings by major Indian companies has also significantly improved over the years. The Pharmaceutical industries are growing at a fast pace registering an annual growth of 8-9%. Considering the advantages like globalisation, information & technology, competent workforce, legal & financial framework that India has, the International Pharmaceutical Industry is finding greater opportunities in India. This paper presents a review on Pharmaceutical market in India with respect to its current status, generic market, government initiatives, challenges and its future perspectives.
Subjects
Pharmaceutical SciencesAsk about this article
Answers come only from this article's title, abstract and keywords, each sentence pointing to where it comes from. Your question is sent to OpenAI to write the answer. Scholars Central does not store it.
Similar by topic
Review article · 2023
Transfusion-Induced Hepatitis-C Virus Infections: Understanding the Current Indian and International Scenario
Conference abstract
The pharmacoeconomic scenario in current Indian health care system
Editorial · 2017
Pharmaceutical Care Services: Indian Scenario
Conference abstract · 31 Jul 2017
Strategies to modify the current usage of antimicrobials in Indian animal health sector
More from this journal
The newest in Pharmaceutical Regulatory Affairs: Open Access.
Article · 13 Feb 2026
Regulatory Scenario of Pharmaceuticals during COVID-19 Pandemic in India
Article · 11 Feb 2026
EU GMP Annex 1 of 2022: A View in Depth
Article · 11 Feb 2026
Standard Formats Used in Drug Regulatory Submissions and Software Used
Conferences in this field
Upcoming conferences in this field.
Follow
New articles from what you follow go into your email digest, once you agree to alert emails.
- JournalPharmaceutical Regulatory Affairs: Open Access
- SubjectPharmaceutical Sciences
- BylineArticles whose byline prints “Hitesh Badgujar”

